Remove services
article thumbnail

Expanded Medicare Telehealth Coverage for Opioid Use Disorder Treatment Services Furnished by Opioid Treatment Programs

Healthcare Law Today

Starting January 1, 2023, Medicare will cover telehealth-based treatment services delivered by federally-accredited opioid treatment programs (OTPs), commonly referred to as “methadone clinics.” CMS also extended coverage for SUD treatment services provided via telehealth.

article thumbnail

Bicycle Health, Wellpath to Provide Opioid Use Disorder Treatment to Federal Bureau of Prisons

HIT Consultant

. – The collaboration will enable patients to access Bicycle Health’s evidence-based, life-saving clinical care model delivering virtual Medication for Opioid Use Disorder (MOUD) services to individuals living in the FBOP’s Residential Reentry Centers (RRC).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Senate Committee’s PREVENT Pandemics Act Draft Released: What to Know

Healthcare Law Today

Provides grants to eligible entities for research and demonstration projects that support the improvement of emergency medical services and trauma care in rural areas. The pilot program, which will wind down at the end of 2027, first requires the FDA to issue guidance on implementation and to provide regular reporting on projects.

article thumbnail

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

Should the final rules limit the issuance of prescriptions of controlled medications to the FDA-approved indications contained in the FDA-approved labeling for those medications? DEA has specifically requested feedback on whether it should limit telemedicine prescribing to only the drug’s FDA-approved indications. 21 U.S.C. §

article thumbnail

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps 

Bill of Health

DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone. Death from overdoses is the leading cause of death in the immediate post-release period,” part four of the report states.

article thumbnail

Five Public Health Needs for Digital Health Technology

The Digital Health Corner

The Substance Abuse and Mental Health Services Administration recently released a free mobile app for clinicians called MATx. The Agency for Healthcare Research and Quality is launching a three-year $19M initiative focusing on mobile apps and telehealth aids for rural physicians in efforts to treat opioid addiction.

article thumbnail

Biden-?Harris Admin Awards $1.5B to Address Overdose Epidemic

HIT Consultant

Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded nearly $1.5 – Releasing New Guidance to Support and Facilitate Greater Access to FDA-approved naloxone products. What You Should Know: – The U.S